A Clinical Trial of Ginseng in Diabetes

A Clinical Trial of Ginseng for Glucose Intolerance

Status

Completed

Phases

Early Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00781534

Enrollment

Registered

2008-10-29

Start date

2003-09-30

Completion date

2008-09-30

Last updated

2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

Health Supplements, Ginseng, Diabetes

Brief summary

a clinical study of Ginseng its potential affect on diabetes

Detailed description

Comparing three groups (those with & without normal blood sugar levels) to see if there is any clinically significant change in blood sugar levels in relationship to those taking: 1. ginseng 2. ginsenoside RE (a type of metabolized ginseng) 3. placebo

Interventions

DRUGGinseng

Each of the 3 arms will be compared to determine if there is any clinical difference in blood sugars between the 3 groups

DRUGginsenoside RE

active metabolite of ginseng

DIETARY_SUPPLEMENTPlacebo (sugar pill)

placebo group

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

BASIC_SCIENCE

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* ages 18-65 * healthy, non-diabetic * healthy, impaired glucose tolerance/mild diabetes (no medications required)

Exclusion criteria

* impaired glucose tolerance (borderline diabetes that requires medications) * diabetes (requiring medications) * caffeine sensitivity * known cardiac, peripheral vascular diseases * arrhythmias (irregular heart rhythms)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026